Patent · US Active

Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation

US7901682B2 · kind B2 · utility

6Cited by
42References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 13, 2006
Grant dateMar 8, 2011
Priority date
Expiry dateJul 20, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions are disclosed that are useful for the prevention and/or treatment of cancer, angiogenesis, and inflammation. The beneficial effects of the compositions and methods are achieved through the use of pharmaceutical compositions that include agents that bind sphingolipids or sphingolipid metabolites. In one embodiment the agent is an antibody or antibody derivative. In some embodiments, the agent is a receptor of a sphingolipid or a sphingolipid metabolite. Also disclosed are methods for identifying and isolating therapeutic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.